U.S. Markets open in 9 hrs 3 mins

ImmunoCellular Therapeutics, Ltd. (IMUC)

NYSE MKT - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.2960+0.0205 (+7.4410%)
At close: 3:59PM EDT
People also watch
NWBOGALECLSNAEZSCUR
  • d
    dave
    dave
    IMUC the next DGLT ?
  • J
    James
    James
    I am amazed how they took this phase 3 of a serious cancer treatment to this level. This is a scream buy all over at this level.
  • J
    James
    James
    Mark this! there will be partner announced very soon!
  • J
    James
    James
    What did I tell you? This is a 2bucks stock
  • d
    dave
    dave
    fasten your seat belts !
    Imagei-am-a-lucky-artefact
  • e
    ed
    ed
    .this could have been worse for an earnings report. but did take a lot of what yesterday gained. like @al said, hopefully they throw a positive nugget at us in next week's call. plenty of time to get back on track. all is not lost with this one.
  • L
    LL
    LL
    I used to trade IMUC 1-2 years ago. The chart looks scary. ICT-107 is stalled due to no more money, company keeps losing cash every quarter, assets reducing, liabilities increasing, etc. Can someone tell me of a catalyst? I am not bashing the company as I had faith in it many years ago but is there a reason to invest in IMUC? I will say I like it at 25c but I may love it at 10c too :)
  • a
    al
    al
    There you have it. Partnership or buyout on the cards, wonder if there will be more news in the call next week
  • B
    Brianna
    Brianna
    IMUC has just seen the last of the selling. Looks like a potential push higher is in store. awesom_sto-cks recently alerted this company i think. google them.
  • T
    Tek
    Tek
    Could someone share some links to more information on ICT-107? Their PRs don't include much information about the Trial results.
  • h
    hawaiifirstchoice
    hawaiifirstchoice
    certainly be nice to see some green
  • s
    sam
    sam
    What's the reason for this pop ?
    Pump and dump ?
  • G
    Guapo
    Guapo
    headed to another RS soon
  • R
    Robert
    Robert
    this stock is the worst ever
  • D
    DavidS
    DavidS
    MM after your shares
  • B
    Brady
    Brady
    But why
  • C
    Crecy
    Crecy
    Take a look at AVEO - already recommended for Approval in the EU. Tivozanib for Renal cancer. Approval date soon, end Aug.
  • B
    Brady
    Brady
    Well this isn't exactly what I expected at all.
  • B
    Brady
    Brady
    7million% run?
  • f
    flow
    flow
    Imuc sold shares to raise 5 million. The price is at the lowest conversion price now. My take the company has some news ( a bone ) to release now the offer has closed. They need to give those VCs some news. I think we get news in the very short term. I bought in today at .35. I think we can see a 30%/50% pop in short order if we get the news